BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 37523130)

  • 21. The histone lysine methyltransferase KMT2D sustains a gene expression program that represses B cell lymphoma development.
    Ortega-Molina A; Boss IW; Canela A; Pan H; Jiang Y; Zhao C; Jiang M; Hu D; Agirre X; Niesvizky I; Lee JE; Chen HT; Ennishi D; Scott DW; Mottok A; Hother C; Liu S; Cao XJ; Tam W; Shaknovich R; Garcia BA; Gascoyne RD; Ge K; Shilatifard A; Elemento O; Nussenzweig A; Melnick AM; Wendel HG
    Nat Med; 2015 Oct; 21(10):1199-208. PubMed ID: 26366710
    [TBL] [Abstract][Full Text] [Related]  

  • 22. KMT2D maintains neoplastic cell proliferation and global histone H3 lysine 4 monomethylation.
    Guo C; Chen LH; Huang Y; Chang CC; Wang P; Pirozzi CJ; Qin X; Bao X; Greer PK; McLendon RE; Yan H; Keir ST; Bigner DD; He Y
    Oncotarget; 2013 Nov; 4(11):2144-53. PubMed ID: 24240169
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histone Methyltransferase KMT2D Regulates H3K4 Methylation and is Involved in the Pathogenesis of Ovarian Cancer.
    Li M; Shi M; Xu Y; Qiu J; Lv Q
    Cell Transplant; 2021; 30():9636897211027521. PubMed ID: 34705580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular pathogenic pathways in extranodal NK/T cell lymphoma.
    de Mel S; Hue SS; Jeyasekharan AD; Chng WJ; Ng SB
    J Hematol Oncol; 2019 Apr; 12(1):33. PubMed ID: 30935402
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The identification of gene signatures in patients with extranodal NK/T-cell lymphoma from a pair of twins.
    Wang Y; Tan H; Yu T; Ma X; Chen X; Jing F; Zou L; Shi H
    BMC Cancer; 2021 Dec; 21(1):1303. PubMed ID: 34872521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histone H3 lysine 4 methyltransferase KMT2D.
    Froimchuk E; Jang Y; Ge K
    Gene; 2017 Sep; 627():337-342. PubMed ID: 28669924
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Histone methyltransferase KMT2D contributes to the protection of myocardial ischemic injury.
    Liu SB; Meng XM; Li YM; Wang JM; Guo HH; Wang C; Zhu BM
    Front Cell Dev Biol; 2022; 10():946484. PubMed ID: 35938163
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Genetic mutational status of genes regulating epigenetics: Role of the histone methyltransferase KMT2D in triple negative breast tumors.
    Morcillo-Garcia S; Noblejas-Lopez MDM; Nieto-Jimenez C; Perez-Peña J; Nuncia-Cantarero M; Győrffy B; Amir E; Pandiella A; Galan-Moya EM; Ocana A
    PLoS One; 2019; 14(4):e0209134. PubMed ID: 30990809
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bortezomib Inhibits Extranodal Natural Killer/T Cell Lymphoma, Nasal Type by Targeting NF-κB Signaling Pathway].
    Li JH; Zhang L; Feng Y; Zou LQ
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2019 May; 50(3):311-316. PubMed ID: 31631595
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicopathological study of pulmonary extranodal nature killer/T-cell lymphoma, nasal type and literature review.
    Ding W; Wang J; Zhao S; Yang Q; Sun H; Yan J; Gao L; Yao W; Zhang W; Liu W
    Pathol Res Pract; 2015 Jul; 211(7):544-9. PubMed ID: 25953340
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Extranodal natural killer/T-cell lymphoma of the breast: a retrospective clinicopathological analysis of a consecutive 11-year case series.
    Liu W; Chen Z; Li F; Zhang W; Liu W; Zhao S
    Orphanet J Rare Dis; 2021 Nov; 16(1):479. PubMed ID: 34794461
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extranodal NK/T Cell Lymphoma, Nasal Type (ENKTL-NT): An Update on Epidemiology, Clinical Presentation, and Natural History in North American and European Cases.
    Haverkos BM; Pan Z; Gru AA; Freud AG; Rabinovitch R; Xu-Welliver M; Otto B; Barrionuevo C; Baiocchi RA; Rochford R; Porcu P
    Curr Hematol Malig Rep; 2016 Dec; 11(6):514-527. PubMed ID: 27778143
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HKDC1 C-terminal based peptides inhibit extranodal natural killer/T-cell lymphoma by modulation of mitochondrial function and EBV suppression.
    Chen Q; Feng J; Wu J; Yu Z; Zhang W; Chen Y; Yao P; Zhang H
    Leukemia; 2020 Oct; 34(10):2736-2748. PubMed ID: 32203147
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EZH2 K63-polyubiquitination affecting migration in extranodal natural killer/T-cell lymphoma.
    Li B; Zhou Q; Wan Q; Qiao X; Chen S; Zhou J; Wuxiao Z; Luo L; Ng SB; Li J; Chng WJ
    Clin Epigenetics; 2023 Nov; 15(1):187. PubMed ID: 38031139
    [TBL] [Abstract][Full Text] [Related]  

  • 35. KMT2D regulates specific programs in heart development via histone H3 lysine 4 di-methylation.
    Ang SY; Uebersohn A; Spencer CI; Huang Y; Lee JE; Ge K; Bruneau BG
    Development; 2016 Mar; 143(5):810-21. PubMed ID: 26932671
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High IL-6 expression in the tumor microenvironment is associated with poor prognosis of patients with extranodal natural / killer T-cell lymphoma (ENKTL).
    Rong Q; Gao Y; Cai Q; Wang X; Bai B; Ping L; He H; Rao H; Zhang Y; Li Z; Cai Q; Jiang W; Huang H
    Expert Rev Anticancer Ther; 2021 Jan; 21(1):121-127. PubMed ID: 33397158
    [No Abstract]   [Full Text] [Related]  

  • 37. Both c-Myc and Ki-67 expression are predictive markers in patients with extranodal NK/T-cell lymphoma, nasal type: a retrospective study in China.
    Huang X; Sun Q; Fu H; Zhou X; Guan X; Wang J
    Pathol Res Pract; 2014 Jun; 210(6):351-6. PubMed ID: 24642368
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of T-cell receptor signalling pathway components in extranodal NK/T-cell lymphoma.
    Miyata-Takata T; Chuang SS; Takata K; Toji T; Maeda Y; Sato Y; Yoshino T
    Histopathology; 2018 Dec; 73(6):1030-1038. PubMed ID: 30102799
    [TBL] [Abstract][Full Text] [Related]  

  • 39. KMT2D inhibits the growth and metastasis of bladder Cancer cells by maintaining the tumor suppressor genes.
    Sun P; Wu T; Sun X; Cui Z; Zhang H; Xia Q; Zhang D
    Biomed Pharmacother; 2019 Jul; 115():108924. PubMed ID: 31100540
    [TBL] [Abstract][Full Text] [Related]  

  • 40. EGR1 as a potential marker of prognosis in extranodal NK/T-cell lymphoma.
    Lee JY; Kim JH; Bang H; Cho J; Ko YH; Kim SJ; Kim WS
    Sci Rep; 2021 May; 11(1):10342. PubMed ID: 33990633
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.